[go: up one dir, main page]

CA2173876A1 - Carbamates d'alcoxyalkyle obtenus a partir d'imidazol(1,2-a)pyridines - Google Patents

Carbamates d'alcoxyalkyle obtenus a partir d'imidazol(1,2-a)pyridines

Info

Publication number
CA2173876A1
CA2173876A1 CA002173876A CA2173876A CA2173876A1 CA 2173876 A1 CA2173876 A1 CA 2173876A1 CA 002173876 A CA002173876 A CA 002173876A CA 2173876 A CA2173876 A CA 2173876A CA 2173876 A1 CA2173876 A1 CA 2173876A1
Authority
CA
Canada
Prior art keywords
pyridines
imidazo
alkoxy alkyl
alkyl carbamates
carbamates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002173876A
Other languages
English (en)
Other versions
CA2173876C (fr
Inventor
Georg Rainer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda GmbH
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2173876A1 publication Critical patent/CA2173876A1/fr
Application granted granted Critical
Publication of CA2173876C publication Critical patent/CA2173876C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Luminescent Compositions (AREA)
CA002173876A 1993-10-11 1994-10-08 Carbamates d'alcoxyalkyle obtenus a partir d'imidazol(1,2-a)pyridines Expired - Fee Related CA2173876C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH304793 1993-10-11
CH3047/93-3 1993-10-11
PCT/EP1994/003326 WO1995010518A1 (fr) 1993-10-11 1994-10-08 CARBAMATES D'ALCOXYALKYLE OBTENUS A PARTIR D'IMIDAZOL(1,2-a)PYRIDINES

Publications (2)

Publication Number Publication Date
CA2173876A1 true CA2173876A1 (fr) 1995-04-20
CA2173876C CA2173876C (fr) 2005-09-27

Family

ID=4247423

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002173876A Expired - Fee Related CA2173876C (fr) 1993-10-11 1994-10-08 Carbamates d'alcoxyalkyle obtenus a partir d'imidazol(1,2-a)pyridines

Country Status (26)

Country Link
US (1) US5719161A (fr)
EP (1) EP0723544B1 (fr)
JP (1) JP3526305B2 (fr)
KR (1) KR100339059B1 (fr)
CN (1) CN1042633C (fr)
AT (1) ATE200672T1 (fr)
AU (1) AU685176B2 (fr)
BG (1) BG100459A (fr)
CA (1) CA2173876C (fr)
CZ (1) CZ290325B6 (fr)
DE (1) DE59409735D1 (fr)
DK (1) DK0723544T3 (fr)
EE (1) EE03262B1 (fr)
ES (1) ES2157992T3 (fr)
FI (1) FI961564L (fr)
GR (1) GR3035943T3 (fr)
HU (1) HU220066B (fr)
NO (1) NO305864B1 (fr)
NZ (1) NZ275419A (fr)
PL (1) PL176424B1 (fr)
PT (1) PT723544E (fr)
RO (1) RO118428B1 (fr)
RU (1) RU2139288C1 (fr)
SK (1) SK283264B6 (fr)
UA (1) UA48122C2 (fr)
WO (1) WO1995010518A1 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10505333A (ja) * 1994-07-28 1998-05-26 ビイク グルデン ロンベルク ヒェーミッシェ ファブリーク ゲゼルシャフト ミット ベシュレンクテル ハフツング イミダゾピリジン−アゾリジノン
DE59712297D1 (de) * 1996-01-26 2005-06-09 Altana Pharma Ag 3-alkylimidazopyridine
AU1545297A (en) * 1996-01-26 1997-08-20 Byk Gulden Imidazopyridine halides
DE19602855A1 (de) * 1996-01-26 1997-07-31 Byk Gulden Lomberg Chem Fab Neue 3-Methylimidazopyridine
SE9802794D0 (sv) 1998-08-21 1998-08-21 Astra Ab New compounds
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6780880B1 (en) * 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
SE0102808D0 (sv) * 2001-08-22 2001-08-22 Astrazeneca Ab New compounds
DE10145457A1 (de) 2001-09-14 2003-04-03 Basf Ag Substituierte Imidazo[1,2-a]-5,6,7,8-tetrahydropyridin-8-one, Verfahren zu ihrer Herstellung, sowie deren Verwendung zur Herstellung von Imidazo[1,2,-a]pyridinen
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
KR101179012B1 (ko) 2003-03-10 2012-09-03 니코메드 게엠베하 로플루미라스트 신규한 제조 방법
EP1974730A1 (fr) 2003-11-03 2008-10-01 AstraZeneca AB Dérivés d'imidazo[1,2-a]pyridine pour l'utilisation dans le traitement des troubles du sommeil provoqués par un reflux gastro-oesophagien silencieux
EP1861074B1 (fr) * 2005-03-16 2013-04-24 Takeda GmbH Forme de dosage cachant le goût comprenant du roflumilaste

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU117992A1 (ru) * 1958-04-11 1958-11-30 Н.В. Олехнович Устройство дл отсчета и записи на рассто нии показаний стрелочных приборов
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
US4725601A (en) * 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
EP0228006A1 (fr) * 1985-12-16 1987-07-08 Fujisawa Pharmaceutical Co., Ltd. Composés d'imidazopyridine et procédés pour leur préparation
NZ221996A (en) * 1986-10-07 1989-08-29 Yamanouchi Pharma Co Ltd Imidazo-pyridine derivatives and pharmaceutical compositions
US4831041A (en) * 1986-11-26 1989-05-16 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridine compounds and processes for preparation thereof
GB8722488D0 (en) * 1987-09-24 1987-10-28 Fujisawa Pharmaceutical Co Imidazopyridine compound
JPH02270873A (ja) * 1989-03-13 1990-11-05 Fujisawa Pharmaceut Co Ltd イミダゾピリジン化合物およびその製造法

Also Published As

Publication number Publication date
NO961414D0 (no) 1996-04-10
HUT73851A (en) 1996-09-30
HK1011681A1 (en) 1999-07-16
FI961564A7 (fi) 1996-04-10
US5719161A (en) 1998-02-17
ATE200672T1 (de) 2001-05-15
EE03262B1 (et) 2000-04-17
PL176424B1 (pl) 1999-05-31
RU2139288C1 (ru) 1999-10-10
CN1042633C (zh) 1999-03-24
FI961564A0 (fi) 1996-04-10
NZ275419A (en) 1996-12-20
UA48122C2 (uk) 2002-08-15
AU685176B2 (en) 1998-01-15
NO961414L (no) 1996-06-10
SK45096A3 (en) 1997-01-08
CZ290325B6 (cs) 2002-07-17
CN1134702A (zh) 1996-10-30
HU220066B (hu) 2001-10-28
JP3526305B2 (ja) 2004-05-10
HU9600890D0 (en) 1996-06-28
PT723544E (pt) 2001-09-28
PL313941A1 (en) 1996-08-05
DK0723544T3 (da) 2001-08-06
BG100459A (bg) 1996-11-29
RO118428B1 (ro) 2003-05-30
AU7937294A (en) 1995-05-04
DE59409735D1 (de) 2001-05-23
ES2157992T3 (es) 2001-09-01
KR960704890A (ko) 1996-10-09
CA2173876C (fr) 2005-09-27
SK283264B6 (sk) 2003-04-01
EP0723544B1 (fr) 2001-04-18
NO305864B1 (no) 1999-08-09
FI961564L (fi) 1996-04-10
GR3035943T3 (en) 2001-08-31
CZ105596A3 (en) 1996-06-12
JPH09503515A (ja) 1997-04-08
EP0723544A1 (fr) 1996-07-31
KR100339059B1 (ko) 2002-11-23
WO1995010518A1 (fr) 1995-04-20

Similar Documents

Publication Publication Date Title
CA2173876A1 (fr) Carbamates d'alcoxyalkyle obtenus a partir d'imidazol(1,2-a)pyridines
CA2133963A1 (fr) Nouvelles mercaptoacetylamido pyricazo[1,2]pyridazine, pyrazolo[1,2]pyridazine, pyridazo[1,2-a][1,2]diazepine et derives de la pyrazolo[1,2-a][1,2]diazepine utilisees comme inhibiteurs de l'enkephalinase et de l'eca
MY111201A (en) New imidazopyridines
CA2135751A1 (fr) Derives de 4-mercaptoacetylamino-[2] benzazepinone(3) et leur utilisation comme inhibiteurs de l'enkephalinase
CA2103861A1 (fr) Nouveau 7-(substituant)-8-(substituant-9-(amino substitue)-6-demethyl-6-desoxytetracyclines
CA2160137A1 (fr) Ansamycines bicycliques
AU7122291A (en) 3-arylcarbonyl-1h-indoles useful as therapeutic agents
AU1854088A (en) Personal appliance having shock protection circuitry
AU3708093A (en) Processes for the preparation of amylase inhibitor
IE861997L (en) Zwitterionic bicyclic compounds
NO933395D0 (no) Fremgangsmaate for fremtilling av 5-substituerte pyrrolo(2,3-d)pyrimidiner
AU1450392A (en) Small peptidic compounds useful for the treatment of glaucoma
MX9500228A (es) N-oxidos de 4-arilpiperazinas y 4-arilpiperidinas.
CA2493275A1 (fr) Procede de preparation de nicotinaldehyde aqueux
ZA931063B (en) Treatment of glaucoma.
AU5371694A (en) Use of the tarchonanthus camphoratus
PH30885A (en) Preparation of physostigmie carbamate derivatives from physostigmine.
AU4167293A (en) Heterocyclyl-phenoxyalkyl-piperidinylpyridazines as antiviral agents
SI0723544T1 (en) ALKOXY ALKYL CARBAMATES OF IMIDAZO(1,2-a)PYRIDINES
AU3722593A (en) Compositions for the treatment of glaucoma
AU6217794A (en) Use of triazine compounds as anxiolytics
AU4041493A (en) Shuttlecock of various uses
GB9302184D0 (en) Improvements relating to the formation of cartosn
AU7633594A (en) Ruthenium red as an inhibitor of the immune response
GB9402762D0 (en) Preparation of dicyanobenzenes by ammonoxidation

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed